Bird & Bird's latest BrandWrites article: Hugo Boss versus Hugo Boss: Lessons from Lycett’s Antics brandwrites.law/hugo-boss-vers…

A Skykick in the Teeth - Arnold LJ holds Sky's Trade Marks applied for in bad faith: twobirds.com/en/news/articl…

Very interesting assessment of data re #Covid_19 transmission. Actual testing data. Not model outputs.

Congratulations to Benoit Van Asbroeck and the rest of the Bird & Bird team in Brussels for a great result. #cjeu #Copyright

Trade Secrets – Interim injunction to prevent importation of "infringing goods" - check out our article on the recent High Court decision here: twobirds.com/en/news/articl…

I must confess that I found this an extremely interesting discussion. And not a double helix or a hexagon in sight! Excellent piece.

Our latest BioTalk article is now live: Post-Transition Brexit: New MHRA Guidelines on Medical Devices bit.ly/33Hf1xC #MedicalDevices #Brexit #MHRA

This is going to be an interesting one... DCMS Committee inquiry: economics of music streaming mediawrites.law/dcms-committee… via @mediawrites.law

Significant changes are coming to the Hungarian #patentlitigation landscape as after decades of a hard #bifurcation system #infringement courts will be entitled to consider invalidity arguments: twobirds.com/en/news/articl…

This should be a good session with Alexander Ramsey, Chair of the UPC preparatory Committee.

What if the Italian patent translation does not match the text of the European patent? twobirds.com/en/insights/20… #patent #Italian #intellectualproperty

How to protect your brands in the metaverse: managingip.com/article/b1xbyl… Managing IP #NFTs #brandlaw

Wouter Pors takes an in depth look at the rules that were adopted at the recent meetings of the UPC committees, focusing on the most important issues for users of the new system. Read more in our article here: bit.ly/3jcr663 #upc #unitarypatent

Ed Balls

According to the current timeline, the Sunrise Period for the UPC is due to start next month. Businesses will then have 3 months to opt out any patents they do not want to be part of the new system when it comes in to force. Are you prepared? Find out more:bit.ly/3acxRDG

The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the original trade mark of the reference medicinal product. Read our latest BioTalk article on these recent high profile cases. bit.ly/3HKDeZJ